Robert Nachama advises banks and other financial institutions, private equity investors and corporates in connection with public and private debt and equity transactions, including high yield debt offerings and as well as in connection with loan/bond structures, acquisition finance and leveraged finance.
Advised Consus Real Estate AG in connection with the offering of €400 million 9.625% senior secured notes due 2024
Advised Goldman Sachs as selling shareholder in connection with the US$200 million IPO of Jumia Technologies AG on the Nasdaq.
Advised BNP Paribas and UniCredit Bank AG on the US$400 million capital increase of Symrise AG.
Advised Swiss Zur Rose Group AG, Europe's largest online pharmacy and one of the leading medical wholesalers in Switzerland, on its CHF200 million rights offering, which was completed in connection with the acquisition of the online pharmacy competitor medpex.
Advised Pfleiderer AG on a successful German insolvency law restructuring*
Advised a syndicate of banks on a loan and high yield bond combination for Schmolz + Bickenbach AG*
Advised Techem GmbH on a loan and high yield note*
Advised IVG Immobilien AG on a capital increase with pre-emptive rights and US private placement*
Advised UBS, Berenberg Bank and equinet Bank on the IPO of RIB Software AG with US private placement*
Advised Barclays Bank PLC on a capital increase of Aurubis AG without pre-emptive rights and with US private placement*
Advised Morgan Stanley and Raiffeisen Centrobank on a capital increase of VERBUND AG with pre-emptive rights and US private placement*
Advised Heidelberger Druckmaschinen AG on a capital increase with pre-emptive rights and US private placement*
Advised Volkswagen AG on a capital increase with pre-emptive rights and pre-placement as well as US private placement*
* Matters prior to working for White & Case.